Aug 4 - Aug 29across 4 weeksImpact
Ebola Outruns Containment
The Ebola outbreak expanded across the DRC every week, becoming the country’s deadliest outbreak and reaching new zones despite rising vaccination efforts. By month’s end, uncertain vaccine performance, limited doses, conflict, mistrust, and weak surveillance still constrained containment.
Aug 10 - Aug 28across 3 weeksImpact
Vaccine Trust Erodes
The administration advanced a narrower childhood vaccine policy while repeating a disproven vaccine-autism claim, and falling MMR coverage increased measles risk. Two Pennsylvania deaths and the highest US measles case count since domestic elimination gave the political dispute more immediate consequences.
Aug 3 - Aug 28across 4 weeksImpact
GLP-1s Expand, Access Narrows
Lilly strengthened its obesity-drug lead as competitors struggled, new pills showed promise, and demand reached unapproved versions of experimental treatments. Yet high prices, coverage withdrawals, Medicare exclusions, stigma, and physician reluctance kept expanding use from becoming broad access.
Aug 4 - Aug 25across 3 weeksImpact
AI Moves Into Clinical Control
Clinical AI progressed from stakeholder consultations to treatment flags, prior authorization, care pathways, reimbursement, and hospital automation. The FDA then began building a broader oversight structure, while questions about accuracy, bias, validation, and accountability remained unresolved.
Aug 3 - Aug 22across 3 weeksImpact
Food Safety Fails Under Pressure
The Cyclospora outbreak grew past 10,000 illnesses and continued rising even after officials declared it contained. The outbreak, alongside an unusually high number of food recalls, exposed gaps in tracing, reporting, inspection, and response capacity.
Aug 18 - Aug 29across 2 weeksImpact
Gaza Care Collapses Further
War and siege disrupted cancer diagnosis, treatment, medicines, and follow-up care across Gaza, while oxygen shortages threatened premature babies and critically ill patients. By the following week, one hospital had run out of cancer medicines entirely, turning interrupted care into immediate risks of preventable death.
Aug 19 - Aug 24across 2 weeksImpact
Personalized Cancer Vaccines Advance
Moderna and Merck’s personalized mRNA vaccine cleared repeated late-stage melanoma milestones and strengthened the case for therapeutic cancer vaccines. Approval, durability, manufacturing complexity, pricing, and broader effectiveness still separate the result from routine care.
Aug 18 - Aug 20Impact
Health Agency Leadership Shifts
The administration’s expected FDA nominee became formal, while new CDC leadership began signaling different priorities and a changing relationship with scientific staff. Those appointments could reshape approval standards, enforcement, drug safety, and public-health policy.